Advertisement
Research Article

Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy

  • Hamish McManus mail,

    hmcmanus@kirby.unsw.edu.au

    Affiliation: The Kirby Institute, UNSW, Sydney, New South Wales, Australia

    X
  • Catherine C. O'Connor,

    Affiliations: RPA Sexual Health, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, South Western Clinical School, UNSW, Sydney, New South Wales, Australia, Central Clinical School, Sydney University, Sydney, New South Wales, Australia

    X
  • Mark Boyd,

    Affiliation: The Kirby Institute, UNSW, Sydney, New South Wales, Australia

    X
  • Jennifer Broom,

    Affiliation: Department of Infectious Diseases, Nambour General Hospital, Nambour, Queensland, Australia

    X
  • Darren Russell,

    Affiliation: Cairns Sexual Health Service, Cairns, Queensland, Australia

    X
  • Kerrie Watson,

    Affiliation: The Alfred Hospital, Melbourne, Victoria, Australia

    X
  • Norman Roth,

    Affiliation: Prahran Market Clinic, Prahran, Victoria, Australia

    X
  • Phillip J. Read,

    Affiliation: Sydney Sexual Health Centre, Sydney, New South Wales, Australia

    X
  • Kathy Petoumenos,

    Affiliation: The Kirby Institute, UNSW, Sydney, New South Wales, Australia

    X
  • Matthew G. Law, on Behalf of the Australian HIV Observational Database

    Affiliation: The Kirby Institute, UNSW, Sydney, New South Wales, Australia

    Membership of the Australian HIV Observational Database is provided in the Acknowledgments.

    X
  • Published: November 07, 2012
  • DOI: 10.1371/journal.pone.0048839

About the Authors

Hamish McManus, Mark Boyd, Kathy Petoumenos, Matthew G. Law
The Kirby Institute, UNSW, Sydney, New South Wales, Australia
Catherine C. O'Connor
RPA Sexual Health, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Catherine C. O'Connor
South Western Clinical School, UNSW, Sydney, New South Wales, Australia
Catherine C. O'Connor
Central Clinical School, Sydney University, Sydney, New South Wales, Australia
Jennifer Broom
Department of Infectious Diseases, Nambour General Hospital, Nambour, Queensland, Australia
Darren Russell
Cairns Sexual Health Service, Cairns, Queensland, Australia
Kerrie Watson
The Alfred Hospital, Melbourne, Victoria, Australia
Norman Roth
Prahran Market Clinic, Prahran, Victoria, Australia
Phillip J. Read
Sydney Sexual Health Centre, Sydney, New South Wales, Australia

Corresponding Author

Email: hmcmanus@kirby.unsw.edu.au

Competing Interests

Matthew Law has received research grants, consultancy and/or travel grants from: Boehringer Ingelheim; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Janssen-Cilag; Johnson & Johnson; Merck Sharp & Dohme; Pfizer; Roche; and CSL Ltd. Mark Boyd has been a board member for Merck and BMS received research grants, consultancy and/or travel grants from: Merck Sharp & Dohme; Abbott; Gilead; Janssen-Cilag; and from Boehringer Ingelheim. Darren Russell has received research grants, consultancy and/or travel grants from: Janssen-Cilag; Merck Sharp & Dohme; Abbott; and Gilead. Norman Roth has received research grants, consultancy and/or travel grants from Boehringer Ingelheim; ViiV; Merck Sharp & Dohme; and Janssen-Cilag. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: HM KP MGL CCO MB PJR NR KW JB DR. Analyzed the data: HM. Wrote the paper: HM KP MGL CCO MB PJR NR KW JB DR.